Table 2. Demographic data and clinical test results for MERS-CoV–infected dromedary camels imported from Oman to United Arab Emirates, May 2015*.

Camel ID	Age/sex	Purpose of importation	Mucopurulent nasal discharge†	Test results
				RT-PCR (Ct)†‡	Rapid antigen test†§	Serum neutralizing antibody titer†¶
ADFCA-HKU1	4 m/F	Breeding	Moderate	Pos (24.54)	Pos	1:40
ADFCA-HKU2	4 m/F	Breeding	Moderate	Pos (27.59)	Pos	1:40
ADFCA-HKU3	4 m/F	Breeding	Moderate	Pos (28.82)	Neg	1:80
ADFCA-HKU4	7 m/F	Breeding	Moderate	Pos (29.81)	Neg	1:80
ADFCA-HKU5	10 y/F	Breeding	Mild	Pos (30.05)	Neg	1:160

*C_t, cycle threshold; ID, identification; MERS-CoV, Middle East respiratory syndrome; Neg, negative; Pos, positive; RT-PCR, reverse transcription PCR.
†Observations or samples from the second sampling on May 14, 2015.
‡Results were determined by open reading frame 1A and upstream of E gene RT-PCR assays; C_t values were from the open reading frame 1A assay. C_t values from both assays were comparable (data not shown).
§Results were determined by immunochromatographic tests for MERS-CoV nucleocapsid protein (12).
¶Results were determined by pseudoparticle neutralization assays (11).